Visit COVID-19 resources

[Skip to Content]

Eye Journal

Globe size and bevacizumab treatment in retinopathy of prematurity: should we adjust the dose? – (Eye 30, 1401 (November 2016))

Nov 10
2016

Globe size and bevacizumab treatment in retinopathy of prematurity: should we adjust the dose? Eye 30, 1401 (November 2016). doi:10.1038/eye.2016.173 Authors: A J Connor & A Shafiq

  • 10 November 2016

Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’ – (Eye Journal AOP)

Nov 04
2016

Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’ Eye advance online publication, November 4 2016. doi:10.1038/eye.2016.242 Authors: E H C van Dijk & C J F Boon

  • 4 November 2016

Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study – (Eye Journal AOP)

Nov 04
2016

Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study Eye advance online publication, November 4 2016. doi:10.1038/eye.2016.243 Authors: S Kaur & J Sukhija

  • 4 November 2016

Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study – (Eye Journal AOP)

Nov 04
2016

Difluprednate versus prednisolone acetate for inflammation following cataract surgery in pediatric patients: a randomized safety and efficacy study Eye advance online publication, November 4 2016. doi:10.1038/eye.2016.244 Authors: M E Wilson, S R Lambert, D A Plager, D VanderVeen, J Roarty & H O’Halloran

  • 4 November 2016

Response to ‘Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’’ – (Eye Journal AOP)

Nov 04
2016

Response to ‘Comment on ‘Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy’’ Eye advance online publication, November 4 2016. doi:10.1038/eye.2016.245 Authors: P Scholz, L Altay & S Fauser

  • 4 November 2016